Plain-English translation of NCT04986748 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers want to see if they can take a small sample of your tumor, grow it in the laboratory, and test different medications against it to figure out which treatments work best for your specific cancer. This personalized approach—sometimes called 'precision medicine'—may help your doctor choose the most effective therapy if your cancer returns or stops responding to standard treatment.
Sarcomas and melanomas don't always respond the same way to standard treatments, and doctors don't always know in advance which medication will work best for each patient. This study aims to solve that problem by testing the medication on your own tumor cells before using it, so your doctor can make a more informed choice.
You likely qualify if…
You likely don't qualify if…
You would have a biopsy or tissue sample taken from your tumor, which researchers would then use to grow your cancer cells in the lab and test different drugs on them. The goal is to identify which medications are most effective against your specific tumor, information your doctor can use to guide your treatment plan if your cancer progresses. The study targets about 100 participants and is currently recruiting.
AI-generated summary from trial data · Jun 7, 2026 · Not medical advice
Singapore
Enrollment target
~100 participants
Started
September 2020
Primary completion
October 2028
Age range
21 Years – 99 Years
Last updated on clinicaltrials.gov in July 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Valerie Shiwen Yang, BSc, MB BChir, PhD
National Cancer Centre, Singapore
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.